Open access
Open access
Powered by Google Translator Translator

[Abstract Only] Randomized Trial: Polypill for Cardiovascular Disease Prevention in an Underserved Population

19 Sep, 2019 | 08:19h | UTC

Polypill for Cardiovascular Disease Prevention in an Underserved Population – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population – TCTMD (free) AND One daily combo pill helps lower heart disease risk in study of underserved patients – American Heart Association (free) AND Fixed Dose Combination Polypill Can Reduce Barriers to Cardiovascular Care – MedicalResearch.com (free) AND One pill with four drugs may lower heart risks in poor population – Reuters (free) AND All-in-One Pill Reduces Blood Pressure, Cholesterol Levels in U.S. Study – Vanderbilt University Medical Center (free)

Related Randomized Trial: Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases (link to abstract and commentaries)

See also: Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology – Global Heart (free) AND Perspective: The Polypill and the Long Journey to Major Impact (opinion and reviews on the subject) AND Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care (free commentaries)

 


Stay Updated in Your Specialty

No spam, just news.